Molecular and functional analysis of the muscle-specific promoter region of the Duchenne muscular dystrophy gene

Duchenne muscular dystrophy (DMD) gene transcripts are most abundant in normal skeletal and cardiac muscle and accumulate as normal myoblasts differentiate into multinucleated myotubes. In this report we describe our initial studies aimed at defining the cis-acting sequences and trans-acting factors involved in the myogenic regulation of DMD gene transcription. A cosmid clone containing the first exon of the DMD gene has been isolated, and sequences lying upstream of exon 1 were analyzed for homologies to other muscle-specific gene promoters and for their ability to direct muscle-specific transcription of chimeric chloramphenicol acetyltransferase (CAT) gene constructs. The results indicate that the transcriptional start site for this gene lies 37 base pairs (bp) upstream of the 5' end of the published cDNA sequence and that 850 bp of upstream sequence can direct CAT gene expression in a muscle-specific manner. Sequence analysis indicates that in addition to an ATA and GC box, this region contains domains that have been implicated in the regulation of other muscle-specific genes: a CArG box at -91 bp; myocyte-specific enhancer-binding nuclear factor 1 binding site homologies at -58, -535, and -583 bp; and a muscle-CAAT consensus sequence at -394 bp relative to the cap site. Our observation that only 149 bp of upstream sequence is required for muscle-specific expression of a chimeric CAT gene construct further implicates the CArG and myocyte-specific enhancer-binding nuclear factor 1 binding homologies as important domains in the regulation of this gene. On the other hand, the unique profile of myogenic cell line-specific induction displayed by our DMD promoter-CAT gene constructs suggests that other as yet undefined cis-acting sequences and/or trans-acting factors may also be involved.

[1]  R. Horlick,et al.  The upstream muscle-specific enhancer of the rat muscle creatine kinase gene is composed of multiple elements , 1989, Molecular and cellular biology.

[2]  S. Hauschka,et al.  Identification of a myocyte nuclear factor that binds to the muscle-specific enhancer of the mouse muscle creatine kinase gene , 1989, Molecular and cellular biology.

[3]  L. Kunkel,et al.  Alternative splicing of human dystrophin mRNA generates isoforms at the carboxy terminus , 1989, Nature.

[4]  A Taylor,et al.  DNA bending is induced by a transcription factor that interacts with the human c-FOS and alpha-actin promoters. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[5]  K. Campbell,et al.  Association of dystrophin and an integral membrane glycoprotein , 1989, Nature.

[6]  L. Kunkel,et al.  Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts , 1989, Nature.

[7]  P. Einat,et al.  Duchenne muscular dystrophy gene product is not identical in muscle and brain , 1989, Nature.

[8]  R. Schwartz,et al.  Identification of cis-acting regulatory elements of the chicken skeletal α-actin gene promoter , 1989 .

[9]  R. Schwartz,et al.  The chicken skeletal alpha-actin gene promoter region exhibits partial dyad symmetry and a capacity to drive bidirectional transcription , 1988, Molecular and cellular biology.

[10]  L. Kedes,et al.  A common factor regulates skeletal and cardiac alpha-actin gene transcription in muscle , 1988, Molecular and cellular biology.

[11]  E. Southern,et al.  Clones from an 840-kb fragment containing the 5' region of the DMD locus enriched by pulsed field gel electrophoresis. , 1988, Genomics.

[12]  L. Kedes,et al.  Interaction of nuclear proteins with muscle-specific regulatory sequences of the human cardiac alpha-actin promoter , 1988, Molecular and cellular biology.

[13]  J. Mar,et al.  A conserved CATTCCT motif is required for skeletal muscle-specific activity of the cardiac troponin T gene promoter. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Dimauro,et al.  Duchenne muscular dystrophy: Deficiency of dystrophin at the muscle cell surface , 1988, Cell.

[15]  T. Cooper,et al.  Analysis of the upstream regions governing expression of the chicken cardiac troponin T gene in embryonic cardiac and skeletal muscle cells , 1988, The Journal of cell biology.

[16]  L. Kunkel,et al.  Cell and fiber type distribution of dystrophin , 1988, Neuron.

[17]  G. Spizz,et al.  Identification of upstream and intragenic regulatory elements that confer cell-type-restricted and differentiation-specific expression on the muscle creatine kinase gene , 1988, Molecular and cellular biology.

[18]  Simon C Watkins,et al.  Immunoelectron microscopic localization of dystrophin in myofibres , 1988, Nature.

[19]  Hideo Sugita,et al.  Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide , 1988, Nature.

[20]  Jamel Chelly,et al.  Transcription of the dystrophin gene in human muscle and non-muscle tissues , 1988, Nature.

[21]  R. Hodges,et al.  The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle , 1988, Nature.

[22]  P. Law,et al.  Normal myoblast injections provide genetic treatment for murine dystrophy , 1988, Muscle & nerve.

[23]  A. Monaco,et al.  The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein , 1988, Cell.

[24]  P. Schimmel,et al.  DNA-binding site for two skeletal actin promoter factors is important for expression in muscle cells , 1988, Molecular and cellular biology.

[25]  A. Monaco,et al.  A 10-megabase physical map of human Xp21, including the Duchenne muscular dystrophy gene. , 1988, Genomics.

[26]  H. Arnold,et al.  The promoter of the chicken cardiac myosin light chain 2 gene shows cell-specific expression in transfected primary cultures of chicken muscle. , 1988, Nucleic acids research.

[27]  K. Fischbeck,et al.  Duchenne muscular dystrophy gene expression in normal and diseased human muscle. , 1988, Science.

[28]  K. Robzyk,et al.  Expression of the putative Duchenne muscular dystrophy gene in differentiated myogenic cell cultures and in the brain , 1988, Nature.

[29]  M. Davison,et al.  α-actinins and the DMD protein contain spectrin-like repeats , 1988, Cell.

[30]  R. Schwartz,et al.  A 29-nucleotide DNA segment containing an evolutionarily conserved motif is required in cis for cell-type-restricted repression of the chicken alpha-smooth muscle actin gene core promoter , 1988, Molecular and cellular biology.

[31]  M. W. Thompson,et al.  Genetics of Duchenne muscular dystrophy. , 1988, Annual review of genetics.

[32]  H. Weintraub,et al.  Expression of a single transfected cDNA converts fibroblasts to myoblasts , 1987, Cell.

[33]  F. Pieper,et al.  Upstream regions of the hamster desmin and vimentin genes regulate expression during in vitro myogenesis. , 1987, The EMBO journal.

[34]  B. Nadal-Ginard,et al.  Multiple Positive and Negative 5′ Regulatory Elements Control the Cell-Type-Specific Expression of the Embryonic Skeletal Myosin Heavy-Chain Gene , 1987, Molecular and cellular biology.

[35]  L. Kunkel,et al.  Expression of the Duchenne's muscular dystrophy gene in cultured muscle cells. , 1987, The Journal of biological chemistry.

[36]  L. Kedes,et al.  Multiple 5'-flanking regions of the human alpha-skeletal actin gene synergistically modulate muscle-specific expression , 1987, Molecular and cellular biology.

[37]  H. Blau,et al.  Differential patterns of transcript accumulation during human myogenesis , 1987, Molecular and cellular biology.

[38]  A. Monaco,et al.  Conservation of the Duchenne muscular dystrophy gene in mice and humans. , 1987, Science.

[39]  L. Kedes,et al.  CArG boxes in the human cardiac alpha-actin gene are core binding sites for positive trans-acting regulatory factors. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[40]  H. Okayama,et al.  High-efficiency transformation of mammalian cells by plasmid DNA. , 1987, Molecular and cellular biology.

[41]  M. Koenig,et al.  Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals , 1987, Cell.

[42]  B. Luckow,et al.  CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements , 1987, Nucleic Acids Res..

[43]  K. Fischbeck,et al.  Molecular analysis of the Duchenne muscular dystrophy region using pulsed field gel electrophoresis , 1987, Cell.

[44]  C. Morency,et al.  A novel rapid assay for chloramphenicol acetyltransferase gene expression , 1987 .

[45]  J. Chirgwin,et al.  Isolation of RNA using guanidinium salts. , 1987, Methods in enzymology.

[46]  S. L. Berger,et al.  First-strand cDNA synthesis primed with oligo(dT). , 1987, Methods in enzymology.

[47]  R. Hammonds Protein sequence of DMD gene is related to actin-binding domain of alpha-actinin. , 1987, Cell.

[48]  P. Ray,et al.  A cDNA clone from the Duchenne/Becker muscular dystrophy gene , 1987, Nature.

[49]  A. Monaco,et al.  A physical map of 4 million bp around the Duchenne muscular dystrophy gene on the human X-chromosome , 1986, Cell.

[50]  A. Monaco,et al.  Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene , 1986, Nature.

[51]  D. Moore,et al.  Human growth hormone as a reporter gene in regulation studies employing transient gene expression , 1986, Molecular and cellular biology.

[52]  L. Kedes,et al.  Upstream regions of the human cardiac actin gene that modulate its transcription in muscle cells: presence of an evolutionarily conserved repeated motif , 1986, Molecular and cellular biology.

[53]  J. Witkowski Tissue culture studies of muscle disorders: Part 1. Techniques, cell growth, morphology, cell surface , 1986, Muscle & nerve.

[54]  S. Cross,et al.  A cosmid vector for systematic chromosome walking. , 1986, Gene.

[55]  R. Myers,et al.  Detection of single base substitutions by ribonuclease cleavage at mismatches in RNA:DNA duplexes. , 1985, Science.

[56]  H. Blau,et al.  Plasticity of the differentiated state. , 1985, Science.

[57]  P. Daubas,et al.  A comparison between mammalian and avian fast skeletal muscle alkali myosin light chain genes: regulatory implications , 1985, Nucleic Acids Res..

[58]  A. Monaco,et al.  Specific cloning of DNA fragments absent from the DNA of a male patient with an X chromosome deletion. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[59]  M. W. Thompson,et al.  Cloning of the breakpoint of an X;21 translocation associated with Duchenne muscular dystrophy , 1985, Nature.

[60]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[61]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[62]  B. Howard,et al.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells , 1982, Molecular and cellular biology.

[63]  R. Devlin,et al.  Coordinate regulation of contractile protein synthesis during myoblast differentiation , 1978, Cell.

[64]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[65]  L. Greene,et al.  Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[66]  B W Kimes,et al.  Properties of a clonal muscle cell line from rat heart. , 1976, Experimental cell research.

[67]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[68]  Cellular and molecular biology of muscle development , 2022 .